Low-molecular-weight heparin for routine hemodialysis-Reference-Cited by-同舟云学术

Low-molecular-weight heparin for routine hemodialysis

Published:2008-10 Issue: Volume:12 Page:S34-S37
ISSN:1492-7535
Container-title:Hemodialysis International
language:en
Short-container-title:

Author:

DAVENPORT Andrew

Publisher

Wiley

Subject

Nephrology,Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1542-4758.2008.00322.x/fullpdf

Reference12 articles.

1. Anticoagulation options for intermittent haemodialysis (review);Davenport,2006

2. Anticoagulation in patients with acute renal failure treated with continuous renal replacement therapies;Davenport,1998

3. Evaluation of the pharmacokinetics of dalteparin in patients with renal insufficiency;Stöbe,2006

4. Pharmacokinetics of the low molecular weight heparin enoxaparin during 48 h after bolus administration as an anticoagulant in haemodialysis;Guillet,2003

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the injection of low‐molecular weight heparin in the arterial vs. venous blood line for preventing extracorporeal circuit clotting during hemodialysis;Hemodialysis International;2022-01-10

2. Arterial Versus Venous Port Site Administration of Nadroparin for Preventing Thrombosis of Extracorporeal Blood Circuits in Patients Receiving Hemodiafiltration Treatment;Kidney International Reports;2021-02

3. Evaluation of the anticoagulant effect of low‐molecular‐weight heparins based on the anti‐Xa level during haemodialysis;Nephrology;2020-02-18

4. Principles of Hemodialysis;Chronic Kidney Disease, Dialysis, and Transplantation;2019

5. Thrombosis and anticoagulation in the setting of renal or liver disease;Hematology;2016-12-02